CAPTRUST Financial Advisors
MRSN

CAPTRUST Financial Advisors’s Mersana Therapeutics MRSN Stock Holding History

CAPTRUST Financial Advisors’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,670
Closed -$12.4K – 2677
2025
Q2 		$12.4K Buy
1,670
+425
+34% +$3.73K ﹤0.01% 2488
2025
Q1 		$10.7K Buy
+1,245
New +$19.2K ﹤0.01% 2336
2022
Q3 		– Sell
-9
Closed -$1K – 3273
2022
Q2 		$1K Sell
9
-2
-18% -$188 ﹤0.01% 4702
2022
Q1 		$1K Sell
11
-3
-21% -$350 ﹤0.01% 4717
2021
Q4 		$2K Sell
14
-3
-18% -$584 ﹤0.01% 4426
2021
Q3 		$4K Hold
17
– – ﹤0.01% 4044
2021
Q2 		$6K Hold
17
– – ﹤0.01% 3786
2021
Q1 		$7K Sell
17
-63
-79% -$30.6K ﹤0.01% 3602
2020
Q4 		$53K Buy
+80
New +$44.5K ﹤0.01% 1804

Other funds holding MRSN

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AV
Alamea Verwaltungs Edison, New Jersey $135M AUM 36.32% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return